These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23774547)

  • 21. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.
    Borleffs CJ; Ypenburg C; van Bommel RJ; Delgado V; van Erven L; Schalij MJ; Bax JJ
    Heart Rhythm; 2009 Mar; 6(3):305-10. PubMed ID: 19251202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
    van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
    Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
    Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
    Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
    Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
    Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Di Biase L; Mohanty P; Mohanty S; Santangeli P; Trivedi C; Lakkireddy D; Reddy M; Jais P; Themistoclakis S; Dello Russo A; Casella M; Pelargonio G; Narducci ML; Schweikert R; Neuzil P; Sanchez J; Horton R; Beheiry S; Hongo R; Hao S; Rossillo A; Forleo G; Tondo C; Burkhardt JD; Haissaguerre M; Natale A
    Circulation; 2016 Apr; 133(17):1637-44. PubMed ID: 27029350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute hemodynamic effects of biventricular and left ventricular pacing in chronic pacemaker-dependent patients with advanced heart failure].
    Hansen C; Sperzel J; Neumann T; Pitschner HF; Neuzner J
    Z Kardiol; 2003 Oct; 92(10):862-8. PubMed ID: 14579051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Heart Fail Clin; 2017 Jan; 13(1):179-192. PubMed ID: 27886922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Device therapy for acute systolic heart failure and atrial fibrillation.
    Carlson SK; Doshi RN
    Card Electrophysiol Clin; 2015 Sep; 7(3):469-77. PubMed ID: 26304527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy.
    Melo X; Abreu A; Santos V; Cunha P; Oliveira M; Pinto R; Carmo M; Fernhall B; Santa-Clara H
    Scand Cardiovasc J; 2019 Aug; 53(4):197-205. PubMed ID: 31221002
    [No Abstract]   [Full Text] [Related]  

  • 36. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Card Electrophysiol Clin; 2015 Dec; 7(4):735-48. PubMed ID: 26596815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy: a comprehensive review.
    Moskovitch J; Voskoboinik A
    Minerva Med; 2019 Apr; 110(2):121-138. PubMed ID: 30334442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.